These success, together with a previous report displaying that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,two support the strategy of targeting ACKR3 as a novel strategy to modulate the opioid program, which could open up new therapeutic avenues for opioid-similar Diseases. Researchers think that blocking this https://seymourf172wod8.wssblogs.com/profile